GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 281 filers reported holding GLOBUS MED INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,854,584 | -26.0% | 258,904 | -11.3% | 0.06% | -23.2% |
| Q2 2023 | $17,372,522 | +36.7% | 291,779 | +30.1% | 0.08% | +30.2% |
| Q1 2023 | $12,706,561 | +2324.9% | 224,339 | +2450.2% | 0.06% | +2000.0% |
| Q3 2022 | $524,000 | +3.6% | 8,797 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $506,000 | -56.6% | 9,009 | -43.0% | 0.00% | -57.1% |
| Q1 2022 | $1,165,000 | -25.2% | 15,792 | -22.3% | 0.01% | -30.0% |
| Q3 2021 | $1,557,000 | +565.4% | 20,319 | +572.8% | 0.01% | +400.0% |
| Q2 2021 | $234,000 | -95.1% | 3,020 | -96.3% | 0.00% | -97.8% |
| Q4 2019 | $4,752,000 | +239.7% | 80,702 | +194.9% | 0.09% | +287.5% |
| Q3 2019 | $1,399,000 | +66.2% | 27,368 | +84.4% | 0.02% | +33.3% |
| Q3 2018 | $842,000 | -72.7% | 14,838 | -75.7% | 0.02% | -78.3% |
| Q2 2018 | $3,085,000 | +58.6% | 61,141 | +29.2% | 0.08% | +97.6% |
| Q4 2017 | $1,945,000 | – | 47,323 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pembroke Management, LTD | 584,085 | $43,379,993 | 4.64% |
| Sterling Investment Advisors, Ltd. | 167,023 | $12,404,798 | 4.44% |
| Ophir Asset Management Pty Ltd | 306,871 | $22,791,309 | 4.38% |
| Godshalk Welsh Capital Management, Inc. | 72,285 | $5,368,607 | 3.92% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 672,400 | $49,939,148 | 3.30% |
| Provident Investment Management, Inc. | 362,745 | $26,941,071 | 3.19% |
| XXEC, Inc. | 97,600 | $7,248 | 2.91% |
| Van Berkom & Associates Inc. | 809,945 | $60,155 | 2.58% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,424,326 | $105,784,692 | 2.38% |
| Seaport Global Advisors, LLC | 7,647 | $567,943 | 1.97% |